Press release
EXOCRINE PANCREATIC INSUFFICIENCY Market Analysis and Forecast to 2028: COVID-19 and Post-COVID Impact, Opportunities and Trends
To request a free sample, Go To: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=007632
The report includes 10 key players in the EXOCRINE PANCREATIC INSUFFICIENCY market ecosystem that have been strategically profiled, along with the market ranking/share for major players. The key players profiled in the report are:
• Axcan
• Aptalis Pharma Inc.
• Eli Lilly & Co.
• Cilian AG
• Nordmark Arzneimittel GmbH & Co.KG
• Laboratoires Mayoly Spindler
• Abbvie Inc.
• Allergan plc
• Digestive Carew Inc.
• Cilian AG
• Anthera Pharmaceuticals Inc.
• AzuRx Biopharma, Inc.
The research team has conducted a study of the EXOCRINE PANCREATIC INSUFFICIENCY market. This study has indicated a positive outlook for the future based on current and past data as well as an in-depth examination of key trends that could impact the long-term performance of this sector. Based on our findings, we see opportunities for growth in some key specific areas that we believe are ripe for new applications. To determine the amounts of these opportunities, we closely investigated factors such as how accessible the required raw materials were and how easily accessible sources could be to those who would be potentially interested in knowing more about these materials and their unique qualities so that they could consider incorporating them into their manufacturing process or commercializing them.
The study discusses the growth potential of the EXOCRINE PANCREATIC INSUFFICIENCY market on a global scale, by region and by country. The report analyzes how and why market trends affect the market in different parts of the world. Then, it sheds light on opportunities available for companies looking to get involved in this industry irrespective of the product or service they are offering.
Impact of COVID-19 & Post Covid Scenerio
The COVID-19 pandemic has been impacting the industry for the past year. Several financial impacts including disruptions have been felt over a long period of time across diverse markets. Our research has interviewed hundreds of people in the same geographical markets to collect information.
In terms of COVID 19 impact, the EXOCRINE PANCREATIC INSUFFICIENCY market report also includes the following data points:
• Impact of COVID-19
• Government Aids and Policies for Industry Revival
• Companies Recent Developments to Tackle Negative Impact
• Opportunity Window & Post COVID Trend
For any customization, contact us through - https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=007632
Market Segment By therapeutics with focus on market share, consumption trend, and growth rate of EXOCRINE PANCREATIC INSUFFICIENCY Market:
• Pancreatic Enzyme Replacement Therapy (PERT) Drugs
o Creon
o Zenpep
o Pancreaze
o Ultresa
o Viokace
o Pertzye
• Exocrine Pancreatic Insufficiency Drugs, Pipeline Analysis, Sollpura (Liprotamase)
Market Segment By diagnostic tests with focus on market share, consumption trend, and growth rate of EXOCRINE PANCREATIC INSUFFICIENCY Market:
• Blood Tests
• Endoscopic Ultra-Sonography (EUS)
• Magnetic Resonance Imaging (MRI)
• CT Scanning
Global EXOCRINE PANCREATIC INSUFFICIENCY Geographic Coverage:
• North America
o US
o Canada
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Indonesia
o Malaysia
o Rest of Asia Pacific
• Latin America
o Mexico
o Brazil
o Argentina
o Rest of Latin America
• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o South Africa
o Rest of MEA
For any customization, contact us through - https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=007632
Key Matrix
• Base Year: 2021
• Estimated Year: 2022
• CAGR: 2022 to 2030
Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Contact: +1 773 644 5507 / +91 635 396 3987
Email: sales@evolvebi.com
Website: https://evolvebi.com/
About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune's global 2000 companies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release EXOCRINE PANCREATIC INSUFFICIENCY Market Analysis and Forecast to 2028: COVID-19 and Post-COVID Impact, Opportunities and Trends here
News-ID: 2572619 • Views: …
More Releases from Evolve Business Intelligence
Plant-Based Meat Market Forecast to Reach USD 26.98 Billion by 2033
The plant-based meat market is at a pivotal point, marked by strong growth in the past decade but now facing headwinds. While traditional retail channels have seen recent slowdowns, the non-store-based segment, which includes direct-to-consumer (D2C) e-commerce, meal kits, and food service, presents a significant and largely untapped opportunity. This channel allows brands to bypass the challenges of traditional retail, such as intense competition for shelf space and high listing…
Nuclear Power Plant Market Forecast to Reach USD 40.75 Billion by 2033
As the world seeks a clean, reliable, and sustainable energy future, High Temperature Gas-Cooled Reactors (HTGRs) are emerging as a prime candidate to lead the next generation of nuclear power. This advanced reactor technology, which uses a graphite-moderated core and inert helium coolant, offers a unique blend of inherent safety and versatility that extends well beyond traditional electricity generation. While challenges remain, the opportunity for HTGRs to transform the nuclear…
LED Lighting Market Forecast to Reach USD 255.92 Billion by 2035
The global LED lighting market is on a trajectory of significant expansion, fueled by the rising demand for energy-efficient and sustainable lighting solutions. While the market for LED lamps remains strong, luminaires-complete lighting fixtures with integrated LEDs-are emerging as the primary driver of future growth. Valued at an estimated USD 71.59 billion in 2023, the market is projected to surge to over USD 255.92 billion by 2035, with a compound…
Sensor Market Forecast to Reach USD 457.26 Billion by 2032
The global sensor market is at a pivotal point, poised for remarkable growth driven by the proliferation of smart devices, industrial automation, and the Internet of Things (IoT). The market, valued at an estimated USD 241.06 billion in 2024, is projected to expand significantly to approximately USD 457.26 billion by 2032, demonstrating a robust Compound Annual Growth Rate (CAGR) of about 8.5%. Within this dynamic landscape, a key player is…
More Releases for EXOCRINE
Exocrine Pancreatic Insufficiency Epidemiology Forecast Through 2034 Now Availab …
DelveInsight's "Exocrine Pancreatic Insufficiency (EPI) - Epidemiology Forecast - 2034" report delivers an in-depth understanding of Exocrine Pancreatic Insufficiency, historical and forecasted epidemiology, as well as the trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
To know in detail about the Exocrine Pancreatic Insufficiency epidemiology outlook, patient pool segmentation, disease burden, and forecasted trends, Click here: Exocrine Pancreatic Insufficiency Epidemiology Forecast https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epidemiology-forecast-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=mpr
Some of…
Exocrine Pancreatic Insufficiency (EPI) Market CAGR of around 5.9%
Exocrine Pancreatic Insufficiency (EPI) Market
The Exocrine Pancreatic Insufficiency (EPI) Market was valued at USD 3.4 billion in 2024 and is projected to reach USD 5.8 billion by 2034, growing at a CAGR of around 5.9%. Growth is driven by increasing prevalence of chronic pancreatitis, cystic fibrosis, and other digestive disorders, along with rising demand for pancreatic enzyme replacement therapies (PERT).
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71138
Key Market…
Prominent Exocrine Pancreatic Insufficiency Market Trend for 2025: Exocrine Panc …
What Are the Projected Growth and Market Size Trends for the Exocrine Pancreatic Insufficiency Market?
The exocrine pancreatic insufficiency market has seen strong growth in recent years. It is projected to increase from $2.59 billion in 2024 to $2.76 billion in 2025, at a compound annual growth rate (CAGR) of 6.6%. The growth is driven by factors such as increased awareness and diagnosis, the rising prevalence of digestive disorders, an aging…
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease.
Download the sample report at: https://www.pharmaproff.com/request-sample/1024
Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI…
Exocrine Pancreatic Insufficiency Market 2013
Transparency Market Research has published a new market report titled, “Exocrine Pancreatic Insufficiency Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2013 – 2023.” According to the report, the exocrine pancreatic insufficiency market is anticipated to expand at a CAGR of 8.3% from 2015 to 2023 to reach US$2.85 Bn by 2023.
Browse the full Exocrine Pancreatic Insufficiency Market – (Therapeutic – Pancreatic Enzyme Replacement Therapy (Creon, Zenpep,…
Exocrine Pancreatic Insufficiency Market Research and Forecast Report 2023
Transparency Market Research has published a new market report titled, “Exocrine Pancreatic Insufficiency Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2013 - 2023.” According to the report, the exocrine pancreatic insufficiency market is anticipated to expand at a CAGR of 8.3% from 2015 to 2023 to reach US$2.85 Bn by 2023.
Browse the full Exocrine Pancreatic Insufficiency Market - (Therapeutic - Pancreatic Enzyme Replacement Therapy (Creon, Zenpep,…
